Anti-HIV proteinase monoclonal antibody F11.2.32 that inhibits enzyme activity. 1998

R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
Department of Gene Manipulation, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

UI MeSH Term Description Entries
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001703 Biophysics The study of PHYSICAL PHENOMENA and PHYSICAL PROCESSES as applied to living things. Mechanobiology
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015488 HIV Antigens Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens. AIDS Antigens,HIV-Associated Antigens,HTLV-III Antigens,HTLV-III-LAV Antigens,LAV Antigens,Lymphadenopathy-Associated Antigens,T-Lymphotropic Virus Type III Antigens, Human,HIV Associated Antigens,HTLV III Antigens,HTLV III LAV Antigens,Lymphadenopathy Associated Antigens,T Lymphotropic Virus Type III Antigens, Human,Antigens, AIDS,Antigens, HIV,Antigens, HIV Associated,Antigens, HIV-Associated,Antigens, HTLV III,Antigens, HTLV-III,Antigens, HTLV-III-LAV,Antigens, LAV,Antigens, Lymphadenopathy Associated,Antigens, Lymphadenopathy-Associated,Associated Antigens, HIV,Associated Antigens, Lymphadenopathy,III Antigens, HTLV
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III

Related Publications

R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
September 2020, Journal of virology,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
January 1997, Applied biochemistry and biotechnology,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
June 1982, Proceedings of the National Academy of Sciences of the United States of America,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
January 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
July 1999, Microbes and infection,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
February 2021, Monoclonal antibodies in immunodiagnosis and immunotherapy,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
June 1986, Japanese journal of cancer research : Gann,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
January 1989, Journal of neuroscience research,
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
December 1993, AIDS (London, England),
R Stouracova, and J Lescar, and J Brynda, and M M Riottot, and V Chitarra, and M Fabry, and M Horejsi, and P Rezacova, and G Bentley, and J Sedlacek
September 1988, Journal of leukocyte biology,
Copied contents to your clipboard!